BioCentury
ARTICLE | Finance

Ebb & Flow

June 8, 2009 7:00 AM UTC

Triple threat

For those keeping score at home, Carl Icahn's right hand man in biotech, Alexander Denner, has joined the boards of three biotechnology companies in the last month: Biogen Idec Inc. (NASDAQ:BIIB), Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) and Enzon Pharmaceuticals Inc. (NASDAQ:ENZN)...